Cargando…

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker

Forkhead box Q1 (FOXQ1) is a member of the forkhead transcription factor family involved in the occurrence and development of different tumors. However, the specific expression patterns and functions of FOXQ1 in pan-cancer remain unclear. Therefore, we collected the expression, mutation, and clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Qiguan, Yan, Lirong, Xu, Qingbang, Hu, Xianliang, Yang, Yan, Zhu, Ruiwu, Xu, Qian, Yang, Yuchao, Wang, Bengang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475120/ https://www.ncbi.nlm.nih.gov/pubmed/36118871 http://dx.doi.org/10.3389/fgene.2022.944970

Ejemplares similares

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Pan-cancer analysis of the prognostic and immunological roles of DEAD-box helicase 5 (DDX5) in human tumors
por: Liu, Shixuan, et al.
Publicado: (2022)

Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer
por: Lei, Jiangchu, et al.
Publicado: (2022)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009)

Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker
por: Wang, Rui, et al.
Publicado: (2023)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors
por: Liang, Qiuju, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E
por: Zhou, Zhixian, et al.
Publicado: (2023)

Forkhead Box Q1 Is Critical to Angiogenesis and Macrophage Recruitment of Colorectal Cancer
por: Tang, Hui, et al.
Publicado: (2020)

Pan‐cancer analyses reveal multi‐omic signatures and clinical implementations of the forkhead‐box gene family
por: Bi, Xiaoman, et al.
Publicado: (2023)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
por: Xu, Qiqi, et al.
Publicado: (2022)

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate
por: Wang, Zhaotao, et al.
Publicado: (2022)

The Role of Forkhead Box Q1 Transcription Factor in Ovarian Epithelial Carcinomas
por: Gao, Min, et al.
Publicado: (2012)

RecQ mediated genome instability 2 (RMI2): a potential prognostic and immunological biomarker for pan-cancers
por: Wei, Wei, et al.
Publicado: (2022)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)

Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non‐small cell lung cancer
por: Li, Lan, et al.
Publicado: (2019)

Forkhead box F1 functions as a novel prognostic biomarker and induces caspase‑dependent apoptosis in bladder cancer
por: Hao, Yining, et al.
Publicado: (2023)

Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance
por: Cheng, Mei, et al.
Publicado: (2023)

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022)

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
por: Cong, Fengyun, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of PAQR4
por: Wang, Kaibin, et al.
Publicado: (2022)

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer
por: Yang, Zeng, et al.
Publicado: (2022)

The Role of Forkhead Box Family in Bone Metabolism and Diseases
por: Xu, Jianxiang, et al.
Publicado: (2022)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis
por: Liang, Xiao, et al.
Publicado: (2022)

Allograft inflammatory factor 1 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Liu, Xin, et al.
Publicado: (2023)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

High expression of forkhead box M1 (FOXM1) is a poor prognostic biomarker in lung adenocarcinoma
por: Xiao, Hong, et al.
Publicado: (2020)

Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic Factor
por: Onodera, Yoshiaki, et al.
Publicado: (2021)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Gene expression signature of human neuropathic pain identified through transcriptome analysis
por: Hu, Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ar7pit09jlsd9s37g2rtbjmljl